Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kamiya Biomedical Company is a life science organization specializing in the development and manufacture of high-quality diagnostic and research reagents. Founded in 1983, the company provides an extensive portfolio of products including ELISA kits, antibodies, and small molecules for both human and veterinary applications. They are particularly well-known for their K-ASSAY® line of clinical chemistry reagents, which are designed for use on a wide variety of automated chemistry analyzers. Their product offerings support research and clinical diagnostics across diverse therapeutic areas such as oncology, cardiology, immunology, and nephrology. Headquartered in Seattle, Washington, Kamiya serves a global customer base including hospitals, clinical laboratories, and academic research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kamiya Biomedical Company.